8-K: INVO FERTILITY Converts Debt to Preferred Stock

INVO FERTILITY, INC. exchanged a senior secured convertible debenture for Series C-2 Convertible Preferred Stock with Five Narrow Lane LP.

Summary

• INVO FERTILITY, INC. (the Company) and Five Narrow Lane LP (FNL) entered into an Exchange Agreement effective September 29, 2025.
• FNL exchanged a Second Amended and Restated Senior Secured Convertible Debenture Due February 11, 2026, for Series C-2 Convertible Preferred Stock.
• Prior to the exchange, the Company made a partial payment of $217.71 on the debenture, reducing the outstanding amount to $1,334,000.
• The Company issued Series C-2 Preferred Stock with an aggregate stated value of $1,334,000 to FNL in exchange for the debenture.
• As additional consideration for the exchange, the Company agreed to issue 467 additional shares of Series C-2 Preferred Stock to FNL.
• Upon completion of the exchange, the Second Amended and Restated Debenture was paid in full and fully extinguished.

Sentiment

Score: 7

Explanation: The extinguishment of a secured debenture is a positive step for financial stability, reducing debt burden. While preferred stock issuance introduces potential future dilution, it resolves an immediate debt obligation. The overall sentiment is slightly positive due to debt reduction.

Positives

• The extinguishment of the Second Amended and Restated Senior Secured Convertible Debenture reduces the Company's debt obligations.
• The transaction converts a secured debt instrument into equity (preferred stock), potentially improving the Company's balance sheet leverage.

Negatives

• The issuance of Series C-2 Convertible Preferred Stock introduces a new class of equity with potential liquidation preferences and future conversion rights, which could dilute common shareholders.
• The Company issued an additional 467 shares of Series C-2 Preferred Stock as further consideration, increasing the total preferred stock outstanding.

Risks

• Future conversion of the Series C-2 Preferred Stock into common stock could lead to dilution for existing common shareholders.
• Preferred stock typically carries certain rights and preferences (e.g., dividend rights, liquidation preferences) that could impact common shareholders.
• The Company's representation that it has no knowledge of facts leading it to believe it will file for reorganization or liquidation within 90 days, and is not discussing a sale of assets, could imply underlying financial pressures.

Future Outlook

The Company represents that it has no knowledge of any facts or circumstances leading it to believe it will file for reorganization or liquidation under bankruptcy laws within 90 days. It also states it is not currently engaged in discussions regarding a sale of the business or assets, nor is it a party to any related binding or non-binding agreements.

Management Comments

• Steven Shum, Chief Executive Officer, signed the report on behalf of INVO FERTILITY, INC.

Industry Context

This debt-to-equity conversion reflects a common strategy for companies, particularly in growth-oriented sectors like fertility, to manage their capital structure, reduce immediate cash outflows for debt service, and potentially improve financial flexibility. Such transactions can be indicative of a company's efforts to strengthen its balance sheet or manage liquidity in a capital-intensive industry.

Stakeholder Impact

• Shareholders: Potential future dilution from the conversion of Series C-2 Preferred Stock into common stock.
• Creditors: The Second Amended and Restated Debenture held by Five Narrow Lane LP has been fully extinguished, removing that specific debt obligation.

Key Dates

Recommendation

The conversion of a secured debenture to preferred stock reduces immediate debt obligations and improves the balance sheet, which is generally positive. However, the issuance of preferred stock, especially with additional shares as consideration, introduces a new layer of equity with potential future dilution for common shareholders. Without further financial performance data or details on the preferred stock's terms (e.g., conversion price, dividend rate), the overall impact on common equity value is mixed, warranting a 'hold' recommendation as investors assess the long-term implications of this capital restructuring.

Keywords

INVO FERTILITY, IVF, SEC filing, 8-K, debt exchange, preferred stock, convertible debenture, capital restructuring, corporate finance, equity issuance